- Suppression of niacin-induced vasodilation with an antagonist to prostaglandin D2 receptor subtype 1. Lai, E., De Lepeleire, I., Crumley, T.M., Liu, F., Wenning, L.A., Michiels, N., Vets, E., O'Neill, G., Wagner, J.A., Gottesdiener, K. Clin. Pharmacol. Ther. (2007)